Net profit of Gujarat Themis Biosyn rose 34.91% to Rs 14.26 crore in the quarter ended September 2025 as against Rs 10.57 crore during the previous quarter ended September 2024. Sales rose 21.98% to Rs 42.35 crore in the quarter ended September 2025 as against Rs 34.72 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales42.3534.72 22 OPM %49.4244.35 - PBDT21.7115.64 39 PBT18.7514.20 32 NP14.2610.57 35 Powered by Capital Market - Live News

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live News

Gujarat Themis Biosyn announced that the Annual General Meeting(AGM) of the company will be held on 12 September 2025.Powered by Capital Market - Live News

Net profit of Gujarat Themis Biosyn declined 31.57% to Rs 9.06 crore in the quarter ended June 2025 as against Rs 13.24 crore during the previous quarter ended June 2024. Sales declined 7.62% to Rs 35.87 crore in the quarter ended June 2025 as against Rs 38.83 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales35.8738.83 -8 OPM %38.8147.80 - PBDT14.1519.01 -26 PBT12.1217.86 -32 NP9.0613.24 -32 Powered by Capital Market - Live News

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live News